Top 50 Medical Angel Investors in United Kingdom in October 2024
A list of 50 angel investors that invest in Medical startups based in United kingdom. We rank investors based on the number of investments they made in Medical companies from United kingdom. We update this investor list every month.Top 50 Medical Angel Investors in United Kingdom in October 2024
Investor | Medical United Kingdom investments |
---|---|
Jonathan Milner | 11 |
Ian Hogarth | 3 |
Mark Bamforth | 3 |
Matt Clifford | 2 |
Will Martin | 2 |
Taavet Hinrikus | 2 |
Will Brooks | 2 |
Ariel Poler | 2 |
Matt Robinson | 2 |
Michael Pennington | 2 |
Alexander Edward Chesterman | 2 |
Nicholas Edwards | 2 |
Jan Hruska | 2 |
Catherine Lenson | 1 |
Brendan O'Driscoll | 1 |
Catherine Lenson | 1 |
Evelyn Bourke | 1 |
Duncan Grierson | 1 |
John Lloyd | 1 |
Jim Mellon | 1 |
Brian Souter | 1 |
Flavien Kulawik | 1 |
Alex Macdonald | 1 |
Nadav Rosenberg | 1 |
Sachin Agrawal | 1 |
Paul Thandi | 1 |
David Prior | 1 |
Errol Damelin | 1 |
Johnathan Matlock | 1 |
Pa Nolan | 1 |
Yusuf Hamied | 1 |
Robert Taub | 1 |
Jim Mellon | 1 |
Reece Chowdhry | 1 |
Peer Schatz | 1 |
Henry Carleton | 1 |
Jim Breyer | 1 |
Fred Moll, M.D | 1 |
Jon Moulton | 1 |
Arjun Desai | 1 |
Tracy Doree | 1 |
Will Armitage | 1 |
Stephen Bourke | 1 |
Maurice Ferre, M.D. | 1 |
Mark McCamish | 1 |
Inaki Berenguer | 1 |
Mark Cuban | 1 |
David Evans | 1 |
Paul Roy | 1 |
Mark P. Stevenson | 1 |
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Series B
- United Kingdom, United States, Canada
Portfolio highlights
- PhoreMost — PhoreMost is a new-model drug discovery company based in Cambridge, UK: Using its core expertise to open up new ‘druggable’ target space and working with a global network of co-invested academic and industrial collaboration partners, we aim to bring a wide array of novel ‘targeted’ therapies more efficiently to market and pass these cost savingsonto patients.
- Constructive Bio — Constructive is a ground-breaking method for creating wholly artificial genomes and rewriting the genetic code of living things.
- LIfT BioSciences — LIfT BioSciences is a socially-minded Biotech start-up that develops a portfolio of potentially life-saving immuno-oncology cell therapies for different solid tumors using its innate immunity platform. Its goal is to create a Cell Bank with the potential to cure cancer, using Leukocyte Infusion Therapy.LIfT BioSciences was founded in 2016 andheadquartered in London, England.
Ian got a master's in machine learning at Cambridge and loves dystopian robot takeover narratives. Seven years ago, Ian realized being a choirboy came with no street cred, so he started DJing hip-hop, funk, drum & bass, and grime. Ian quit his job at Bain & Company, Singapore to start Songkick.
Show more
Investment focus
- Software, E-Commerce, Internet
- Seed, Pre-Seed, Series A
- United Kingdom, United States, Germany
Portfolio highlights
- Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
- Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
- Fabric — One home for everything. A file explorer and workspace for the internet age. All your drives, clouds, notes, screenshots, links, and files automatically gathered into one self-organizing home. Never forget anything again.
Mark Bamforth is the Operating Partner at Ampersand Capital Partners.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Seed, Funding Round
- United Kingdom, United States
Portfolio highlights
- Dxcover — Dxcover are a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.
- PneumoWave — Empowering Intervention and Prevention for Opioid-Induced Respiratory Depression
- Thymmune Therapeutics — Thymmune Therapeutics is developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease.
Matt co-founded EF after being a consultant at McKinsey & Co. Prior to EF Matt spent his time studying at MIT fuelled by an obsession with R, Python and unusual datasets. EF is the best place for Europe’s top technical individuals to meet and build world-changing startups in London.They select purely on the basis of technical talent, so youcan apply before you have a team or an idea. The intensive 6-month programme is designed to give you the best possible support in the first 200 days of your startup’s life.They have created over 40 startups now worth over $300 million. The startups are funded by some prestigious investors including Balderton Capital, Index Ventures, Octopus Investments and Y Combinator.
Show more
Investment focus
- Software, FinTech, Artificial Intelligence
- Seed, Pre-Seed, Funding Round
- United Kingdom, India, United States
Portfolio highlights
- Koos — KOOS is a simple legal and technological solution for motivating and rewarding your community. Boost your growth by sharing success.
- Patch — Patch is your new neighbourhood space for work, community, and events.
- Flow Engineering — Requirements management, made collaborative
Will Martin - Founder and Director @ Portfolio Ventures
Show more
Investment focus
- FinTech, Financial Services, Software
- Seed, Funding Round, Series A
- United Kingdom, United States
Portfolio highlights
- Bequest — Digital estate planning made easy for professionals and individuals. Securely protect online accounts, cryptocurrencies, emails, media, documents and more.
- Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
- Robin AI — Robin AI is a legal tech company based in London, made up of engineers, lawyers, scientists and operations specialists.
Taavet Hinrikus is co-founder and CEO of TransferWise. Prior to starting TransferWise, Taavet was Skype’s director of strategy until 2008, starting as its first-ever employee. One of the World Economic Forum's Tech Pioneers, Taavet is an adviser to Prime Minister of Estonia on the digital agenda. He’s also a mentor and angel investor; hisinvestments include Tweetdeck, Mendeley, OMGPOP, Property Partner, Sunrise, Improbable and Mapillary.
Show more
Investment focus
- FinTech, Software, Financial Services
- Seed, Series A, Series B
- United Kingdom, United States, Estonia
Portfolio highlights
- Meatable — Meatable is a food production company that produces real and guilt-free meat. With one cell, they are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time they increase food security, without compromising the culinary experience of eating tasty, real meat. They aim to satisfy the world'sappetite for meat without harming people, animals, and the planet.It was founded in 2018 and is headquartered in Delft, South Holland, The Netherlands.
- Open Cosmos — Driven by the vision of making space accessible to anyone, Open Cosmos provides simple and affordable space missions.Open Cosmos went from design to delivery of qb01, their first nanosatellite, in only four months, followed by a launch and deployment in LEO early April 2017. They are currently working with innovative payload developers towardsin-orbit demonstration and constellation deployment to enable services ranging from remote sensing to maritime domain awareness and machine-to-machine communications.
- Unearthly Materials — Unearthly Materials is a transformative materials company focused on delivering practical room-temperature superconductors and powering the century of superconductivity.
Will Brooks - Founder & Director @ Portfolio Ventures
Show more
Investment focus
- Financial Services, FinTech, Software
- Seed, Funding Round, Series A
- United Kingdom, United States
Portfolio highlights
- Bequest — Digital estate planning made easy for professionals and individuals. Securely protect online accounts, cryptocurrencies, emails, media, documents and more.
- Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
- Robin AI — Robin AI is a legal tech company based in London, made up of engineers, lawyers, scientists and operations specialists.
Ariel Poler is the Co-Founder of Reveri Health. Ariel is an Internet entrepreneur, mentor, and investor. He was the founder of IPRO, the first web analytics company, and of Topica, one of the first email communities. Ariel was a board member of Kana Software, LinkExchange, Odeo, LOLapps, and StumbleUpon. He currently serves on the boards of FreedomFinancial Network, MixTent, Strava, and Scan Inc. Ariel’s angel investments include AdMob, Flixster, Slideshare, Xobni, RockYou, and Outright, BrightRoll, Instructables, Causes, Kongregate and NexTag. Ariel holds a B.S. in Mathematics with Computer Science from MIT and an MBA from Stanford University. He is originally from Venezuela and lives in San Francisco with his wife and three children.
Show more
Investment focus
- Software, Social Media, Internet
- Seed, Series A, Angel
- United States, Mexico, United Kingdom
Portfolio highlights
- Reloadly — Reloadly makes it easy for developers to connect with Mobile operator services. We are disrupting a Trillion dollar industry! Mobile Operators are stuck in old school business models, where most of the world is moving to open source platforms for developers to build amazing products. Reloadly is bridging the gap between mobile operators anddevelopers, and at the same time creating new sales channels for the 816 mobile operators around the world.
- Openlytics — Openlytics is a visual analytics platform. It allows Data Workers to create pipelines for data transformation and analysis, in a visual way. Our mission is to empower everyone in the organization to solve data problems, without waiting for developers.Openlytics is an early-stage company, looking to build a founding team that can shape thedirection of the product. We’re seed-funded, remote-first, and hiring.If you're interested in learning more, email us at hello@openlytics.io.
- humm — humm harnesses cutting-edge neuroscience into products that allow people to learn faster and perform better.humm is working to bring the incredible results of neuroscience research out of the lab and into non-invasive wearables that improve the quality of life for everyday people. Our first product is a clinically validated patch that you wearfor 15 minutes to get up to 90 minutes of improved working memory, by gently stimulating the signals in the part of the brain that controls your executive thinking. humm improves your ability to learn and be at your best, allowing people to reconnect with the joy of learning and challenge themselves to continue growing at any stage of life, whether it's for work or personal enjoyment!
Matt Robinson is the CEO and a co-founder at Nested, a property technology company. Prior to this, he founded GoCardless in 2010 and remains on the board of the recurring payment company.
Show more
Investment focus
- Software, FinTech, Financial Services
- Seed, Pre-Seed, Series A
- United Kingdom, United States, Germany
Portfolio highlights
- Kaedim — Kaedim’s product creates 3D content as easily as you can take a photo, 2D content, with your smartphone today.
- Feather — Feather gives you insurance advice for expats in Germany. Our digital insurance agent will help you get the right insurance policies for your need.
- Galileo AI — Galileo AI creates delightful, editable UI designs from a simple text description. It empowers you to design faster than ever.
One of the UK's leading tech angel investors. Active seed and pre-seed stage angel investor in UK based disruptive tech. Prefers businesses venturing into pastures new and keen investing at the pre product stage whether BtoC or B2B.
Twice exited UK based tech entrepreneur with experience operating tech businesses in 20 countries in multiplelanguages. Co-founded Gumtree with Simon Crookall which was acquired by Ebay and Slando acquired by Naspers.
Show more
Investment focus
- Software, SaaS, Financial Services
- Seed, Pre-Seed, Funding Round
- United Kingdom, United States, Spain
Portfolio highlights
- Hubflo — Hubflo is building an all-in-one work OS to help small businesses manage their business. Instead of having 10 complicated and expensive pieces of software, Hubflo offers SMB everything they need to run their business (CRM, projects, invoicing, expenses...) in a single comprehensive, simple and affordable platform.
- FUEL — Where everlasting fanbases are built
- Sidekick — Expertly-managed portfolios for the modern investor
Alex Chesterman is the founder and CEO of Cazoo. He was the Founder & CEO of ZPG Plc, a FTSE-250 listed company.
Previously Alex co-founded Lovefilm, Europe's leading digital movie rental business, which was successfully sold to Amazon. Alex is also one of the UK's most active tech angel investors having backed dozens of early stagedigital startups and was awarded an OBE for services to services to digital entrepreneurship in 2016.
Show more
Investment focus
- E-Commerce, FinTech, Financial Services
- Seed, Pre-Seed, Series A
- United Kingdom, France
Portfolio highlights
- Lick — Lick | Paints, Wallpapers and Supplies. Your Room, Covered
- Pharmacierge — Pharmacierge is the digital e-prescribing service chosen by private clinicians to deliver medication to their patients throughout the UK and worldwide. Clinicians create and transfer e-prescriptions to our pharmacy near London's Harley Street, for free delivery to their patients either the same day or next weekday
- Vyne Technologies — Vyne Technologies is the specialist account-to-account payments platform.
Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.
Show more
Investment focus
- Medical, Health Care, Life Science
- Seed, Funding Round
- United Kingdom
Portfolio highlights
- Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Jan Hruska
Show more
Investment focus
- Medical, Health Care, Life Science
- Seed, Funding Round
- United Kingdom
Portfolio highlights
- Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Catherine is an investor, board director and executive coach. She is based in London and works globally.She is an experienced international C-suite executive with a strong track record in the People, DE&I and ESG fields. Together with Jonathan Lenson. she invests in exceptional early-stage tech companies across the UK, US and Israel, andbrings in-depth previous board experience as both an executive and non-executive director.She writes and speaks on topics including the future of work, corporate culture and purpose, diversity and inclusion, and work/life integration.As part of her coaching practice, she is the first UK-based facilitator to be certified in the Fair Play method. Catherine was the first female Managing Partner appointed at SoftBank Investment Advisers, the world’s largest technology investment firm with $175 billion under management in the two SoftBank Vision Funds and SoftBank Latin America Funds. As the founding Chief People Officer for five years (2017-2022), she led the HR, ESG and Real Estate teams globally.An experienced and trusted executive coach at C-suite level, she worked with companies within the Vision Fund portfolio on leadership, talent, DE&I, ESG, and operating challenges, including as a Board Director.Catherine built SBIA’s ESG practice and designed its strategy for Social Impact. She led SoftBank’s early stage venture funds focused on diverse founders, including the $100m+ SB Opportunity Fund (US) and Emerge (EMEA), including as an Investment Committee member.Catherine is a Young Global Leader of the World Economic Forum (Class of 2021) and a founding member of Sustainability30 (which brings together Chief Sustainability Officers from 30 of the world’s leading companies).She spent the formative years of her career at UBS AG, Switzerland’s leading financial services firm, and is proud to have progressed from intern to Managing Director in the same firm. In her final role there, she led Reward for UBS across the UK and EMEA region.
Show more
Investment focus
- Software, Information Technology, Internet
- Seed, Pre-Seed, Grant
- United Kingdom, Israel
Portfolio highlights
- Fertifa — Fertifa is an innovative employer benefit solution making fertility care more accessible and affordable.The company works with employers to offer a valuable employee benefit which bridges the gap between an employer and their employees when dealing with the sensitivity and privacy of employees’ reproductive issues. It also offers guidance andadvice, next-generation fertility treatment, and access to a range of holistic services for the best chance of success. The company was founded in 2019 and based in London, United Kingdom.
- Tangent — Tangent: Your bridge from diverse backgrounds to tech sales roles via referrals, coaching, and unique video pitches. Create a free account today!
- Surfboard — Surfboard WFM features integrated forecasting, capacity planning, automated scheduling and performance analytics for modern support teams.
Brendan O'Driscoll is the Chief Product Officer of KOHO.
Show more
Investment focus
- Health Care, Wellness, Artificial Intelligence
- Seed, Pre-Seed, Series A
- United States, India, United Kingdom
Portfolio highlights
- Betterhalf — Best matrimony app in India with AI matchmaking. Get compatible life partner from lakhs of genuine, Govt ID and selfie verified profiles of brides & grooms. Download Betterhalf marriage app now!
- Betty Labs — Spotify is a digital music service that gives you access to millions of songs.
- Levels — Levels helps you see how food affects your health with data from biosensors like continuous glucose monitors (CGMs)
Catherine is an investor, board director and executive coach. She is based in London and works globally.She is an experienced international C-suite executive with a strong track record in the People, DE&I and ESG fields. Together with Jonathan Lenson. she invests in exceptional early-stage tech companies across the UK, US and Israel, andbrings in-depth previous board experience as both an executive and non-executive director.She writes and speaks on topics including the future of work, corporate culture and purpose, diversity and inclusion, and work/life integration.As part of her coaching practice, she is the first UK-based facilitator to be certified in the Fair Play method. Catherine was the first female Managing Partner appointed at SoftBank Investment Advisers, the world’s largest technology investment firm with $175 billion under management in the two SoftBank Vision Funds and SoftBank Latin America Funds. As the founding Chief People Officer for five years (2017-2022), she led the HR, ESG and Real Estate teams globally.An experienced and trusted executive coach at C-suite level, she worked with companies within the Vision Fund portfolio on leadership, talent, DE&I, ESG, and operating challenges, including as a Board Director.Catherine built SBIA’s ESG practice and designed its strategy for Social Impact. She led SoftBank’s early stage venture funds focused on diverse founders, including the $100m+ SB Opportunity Fund (US) and Emerge (EMEA), including as an Investment Committee member.Catherine is a Young Global Leader of the World Economic Forum (Class of 2021) and a founding member of Sustainability30 (which brings together Chief Sustainability Officers from 30 of the world’s leading companies).She spent the formative years of her career at UBS AG, Switzerland’s leading financial services firm, and is proud to have progressed from intern to Managing Director in the same firm. In her final role there, she led Reward for UBS across the UK and EMEA region.
Show more
Investment focus
- Software, Information Technology, Internet
- Seed, Pre-Seed, Grant
- United Kingdom, Israel
Portfolio highlights
- Fertifa — Fertifa is an innovative employer benefit solution making fertility care more accessible and affordable.The company works with employers to offer a valuable employee benefit which bridges the gap between an employer and their employees when dealing with the sensitivity and privacy of employees’ reproductive issues. It also offers guidance andadvice, next-generation fertility treatment, and access to a range of holistic services for the best chance of success. The company was founded in 2019 and based in London, United Kingdom.
- Tangent — Tangent: Your bridge from diverse backgrounds to tech sales roles via referrals, coaching, and unique video pitches. Create a free account today!
- Surfboard — Surfboard WFM features integrated forecasting, capacity planning, automated scheduling and performance analytics for modern support teams.
Evelyn was appointed Bupa’s Group CEO in July 2016, having been Acting Group CEO from April 2016. She is also a member of the Bupa Board and Nomination & Governance Committee.She has a strong track record in global executive management and extensive experience in financial services, risk and capital management, and mergers and acquisitions.Evelyn joined Bupa as CFO in September 2012, from Friends Life where she was Chief Executive Officer of its Heritage division. Previously at Friends Provident, she was the Executive Director responsible for strategy, capital and risk and, before that, Chief Financial Officer.Evelyn grew up on a dairy farm in Ireland and she’s the eldest of six. She was one of the first two women in Ireland to qualify as actuaries. She began her career with New Ireland Assurance and Bank of Ireland. She holds an MBA from London Business School and was previously a Non-Executive Director of the IFG Group in Ireland. Evelyn is currently a Non-Executive Director of the Bank of Ireland Group plc and a member of their Audit Committee and Nomination and Governance Committee.On becoming Group CEO in April 2016, Evelyn established a clear Strategic Framework to focus the organisation on delivering for customers.Evelyn believes strongly in promoting diversity in the workplace and empowering people to deliver high standards of service and care for customers.
Show more
Investment focus
- InsurTech, Insurance, Software
- Seed, Pre-Seed, Series B
- United Kingdom
Portfolio highlights
- Hybr — Find your next student accommodation with Hybr, the UK's best student letting platform. Over 5000 happy students served. Click to find your next property.
- Lukango — Lukango takes care of your insurance so you can focus on growing your business, knowing your dream is protected in the right way.
- Klarytee — Klarytee is a SaaS platform that builds security into sensitive content to enable granular control wherever the data goes
Duncan Grierson
Show more
Investment focus
- Water, Medical, CleanTech
- Seed, Series A
- United Kingdom
Portfolio highlights
- Puraffinity — Puraffinity develops targeted materials for water treatment, focused on forever chemicals called PFAS. Our strategic intent is to provide 1 billion people with PFAS safe water by 2030
- Moixa Technology — Moixa Technology develops the Maslow intelligent energy storage solution, enabling homes to store energy and benefit from revenue streams generated by trading energy through GridShare, an SaaS platform that aggregates energy from groups of Maslow energy storage systems. . The company develops smart DC technologies to power DC lighting, computing,electronics from grid-shifted storage or local PV from smart DC hubs, variable DC networks and sockets. The technology and IPR reduces grid peak by shifting DC device load and powering DC devices efficiently without inverters or AC/DC adaptors, together with providing smart control and energy management. The technology aims to address the 1 trillion kwh + lost annually in power conversion, and the significant growing DC demand in homes, offices from ICT, LED lighting and the rise in internet connected devices.
John Lloyd
Show more
Investment focus
- Health Care, Education, Wellness
- Seed, Funding Round, Equity Crowdfunding
- United Kingdom
Portfolio highlights
- Thrive — Thrive Mental Wellbeing - Mental Health Services
- Easy Peasy — Get EasyPeasy parenting tips and activities, personalised for you and your 0-5 year old, from our playful community of parents and experts.
- Elemental Software — Elemental is a digital platform that connects patients health and social care professionals and community health & wellness providers.Health Professionals are able to generate digital social prescriptions for citizens with chronic health risks such as depression, social isolation, type 2 diabetes and obesity, connecting them with qualityassured providers who deliver community based interventions across the domains of exercise, diet/nutrition, social support and mental health.The software is designed as a multi-tenanted cloud service and so can be implemented rapidly. It is highly parameterised and can be customised to suit an individual organisation's functional requirements without compromising its technological core.
Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.
Show more
Investment focus
- Biotechnology, Health Care, Food and Beverage
- Series A, Seed, Funding Round
- United States, United Kingdom, Israel
Portfolio highlights
- Voxia — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
- Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
- The Duppy Share — The Duppy Share Caribbean Rum is the best rum for cocktails, mixed drinks and rum gifts. Try all our rum recipes, from rum and ginger to dark rum punch.
Sir Brian Souter is co-founder and Chairman of Stagecoach plc, having retired as Chief Executive in May 2013.Whilst he does not sit with the Souter Investments team in Edinburgh, Sir Brian is active in all investment decision making processes and sits on the boards of our European bus operators (PolskiBus.com and OnniBus.com) and New Zealandtransport group (InMotion).Sir Brian is currently the Vice-President of the Institute of Chartered Accountants of Scotland.
Show more
Investment focus
- Medical, Commercial, Health Care
- Funding Round
- United Kingdom
Portfolio highlights
- Ryboquin — Ryboquin™ uses its expertise to turn under-developed intellectual property ideas into viable commercial realities. Founded in Scotland, Ryboquin Ltd is a privately held, virtual pharmaceutical company focused on commercialising patented technologies in the area of human cancer medicine.Founded in Scotland, Ryboquin is a privately held, virtualpharmaceutical company focused on commercializing patented technologies in the area of human cancer medicine.
Flavien Kulawik
Show more
Investment focus
- Health Care, Artificial Intelligence, SaaS
- Seed, Funding Round, Series A
- France, United Kingdom
Portfolio highlights
- Adionics — Adionics provides advances ionic solutions such as lithium and iodide extraction, and salts separation.
- Biomemory — Biomemory creates DNA Drives for large corporates and administrations.
- Scienta Lab — Redefining precision immunology
Alex Macdonald is the Co-Founder and CEO of sequel - an investment platform on a mission to help athletes build a legacy for their families and the world. He previously Co-Founded Velocity Black, raised more than $40m in funding, and which was successfully exited to US Bank Capital One in 2023. He is a serial angel investor having invested in 50early stage startups and funds.
Show more
Investment focus
- Software, Artificial Intelligence, FinTech
- Pre-Seed, Seed, Series A
- United Kingdom, United States, France
Portfolio highlights
- Stelia — Stelia stands at the forefront of the AI infrastructure revolution and is driving the transition from Internet 2.0, designed for data movement, to Internet 3.0, designed for data mobility, enabling the seamless flow and processing of data across diverse environments. With its ground-breaking HyperBand platform, Stelia enables businesses toharness the full potential of AI. The company's mission is to become the backbone of the next generation of data mobility, empowering organizations across industries to accelerate innovation, optimize operations, and drive transformative growth. Stelia will be at the gravitational centre of the AI infrastructure ecosystem – a trusted partner and catalyst for change that brings together forward-thinking businesses, technology leaders, and industry experts to shape the future of AI. It was founded in 2021 and is located in London, United Kingdom.
- Harriet — Efficient, cost effective AI for HR that improves the employee experience. Get time back to focus on what counts and let Harriet do the rest | Harriet
- Fundably — Fundably - Get The Right UK Business Loan | Access £1k-£2m
Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.
Show more
Investment focus
- Biotechnology, Artificial Intelligence, Pharmaceutical
- Seed, Pre-Seed, Series A
- United Kingdom, Israel, Singapore
Portfolio highlights
- thymia — Making mental health as objectively measurable as physical health.
- Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
- Loops — Loops is a no-code analytics platform that provides product and data teams with growth opportunities hidden in their data.
Sachin Agrawal
Show more
Investment focus
- Medical, Health Care, Health Diagnostics
- Series A
- United Kingdom
Portfolio highlights
- Hexarad — Hexarad is a radiologist-led radiology company, which combines powerful tech and expert people to provide quick, accurate diagnoses. We have developed the Hexarad Platform, a unique and all-encompassing radiology solution powered by an intelligent allocative efficiency engine.
Paul is the Founder and Chief Executive Officer of the NEC Group, the UK’s leading live events business, which owns; the NEC, ICC, Vox, Resorts World Arena, Utilita Arena Birmingham, The Ticket Factory and Amadeus.He was appointed Group CEO in 2006, bringing over 20 years’ experience in the media industry.Paul has since transformed the Groupinto a customer-centric and data-led organisation, whilst increasing its portfolio of businesses and venues, and leading the company through changes of ownership in 2015 and 2018.
Show more
Investment focus
- Medical, Health Care, Medical Device
- Seed
- United Kingdom
Portfolio highlights
- EDX Medical Group — EDX Medical Group provides innovative digital diagnostic products and services for cancer, cardiovascular disease, neurology, and infectious disease testing.
David Prior is the former chair of the UK's National Health Service.
Show more
Investment focus
- Health Care, Medical, Software
- Seed
- Belgium, United Kingdom
Portfolio highlights
- TORTUS AI — Innovative medical AI which revolutionises the healthcare industry by enhancing clinical operations and patient care. Book a free demo today.
- Awell Health — Ollie is a vast library of over 100 interface blocks with complete Webflow CMS integration. Build beautiful websites in less time than ever.
Errol Damelin is the Founder, CEO, chairman, or original investor and backer of over 75 digital and tech companies around the world, including in the US, the UK, most of Europe, Israel, Indonesia, Brazil, Turkey, South Africa, and Nigeria. He concentrates his efforts on SaaS, fintech, crypto, marketplaces and data analytics as well as on health andwellness. He is also a technologist and has three granted patents to his name with another four pending.Among the companies co-founded by Damelin are groundbreaking fintech company Wonga, and SME banking startup Tide. His early investments include Wise, Cazoo, Purplebricks, K Health, YuLife, Sure, Demyst, Zoe, Farewill, CityMapper, Modifi, UnBabel, Thimble, HiBob, Modifi, Elliptic, Lendingkart, and VivaReal.
Using his own personal equity, Damelin continues to invest early on in the next generation of entrepreneurs so that he can help them succeed. He is not an institutional VC fund and does not maximize the assets under his management. He best describes his approach as Riding Shotgun.Damelin's success as a founder has been recognized by The Guardian, which named him Digital Entrepreneur of the Year in 2011; by Ernst and Young, which named him the UK's Entrepreneur of the Year in 2011 as well; and by TechCrunch, which named him Founder of the Year in 2010.
Show more
Investment focus
- FinTech, Financial Services, Finance
- Seed, Series A, Pre-Seed
- United Kingdom, United States, Israel
Portfolio highlights
- Zelt — Manage everything from HRIS, payroll, pension, devices, apps and more seamlessly in one central hub, for all processes and applications, third-party included. Improve productivity through enhanced employee experience.
- Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
- Ritual — Couple Goals Made Possible. Relationship Support For Busy People, Practical Tools & Expert Feedback
Johnathan Matlock is Co-Founder Science Angel Syndicate.
Show more
Investment focus
- Biotechnology, Medical, Health Care
- Seed, Pre-Seed
- United Kingdom
Portfolio highlights
- Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
- Argonaute RNA — Developing safe and reliable methods of temporarily silencing target genes in different tissue cells.
- Halo Therapeutics — Halo Therapeutics is based in England. Develops safe pan coronavirus antiviral drugs for Covid-19 that can be administered by patients.
Pa Nolan
Show more
Investment focus
- Medical, Delivery, Shipping
- Seed, Funding Round
- Ireland, United Kingdom
Yusuf Hamied is a Cambridge-educated Chemist and the Non-Executive Chairman of the Board of Directors at Cipla, a large generic pharmaceuticals company founded in 1935 by his father, Khwaja Abdul Hamied. Yusuf became a global celebrity for his role in defying Western multinational pharmaceutical companies in order to provide generic AIDS treatmentsand other drugs to treat poor people in the developing world. After completing his doctorate in 1960, Yusuf joined the family company and vowed to break the dominance of foreign multinationals over the Indian pharmaceutical market by developing cheap generic drugs. Yusuf helped persuade the Indian government to change Indian patent law in 1972, permitting medicines to be copied even if they were under international patent, as long as the process was not the same. The law transformed the Indian pharmaceutical industry, enabling his and other companies to grow by manufacturing generic drugs. In 2001 Yusuf convulsed the global healthcare industry by promising and then delivering a triple drug cocktail, Triomune, that helped fight against HIV and AIDS at prices far lower than those available internationally. Yusuf discusses his subsequent anger when, in 2005, the Indian government brought its patent laws in line with those of the developed world, prohibiting the copying of drugs patented after 1995 without a license and his resentment that he had thereafter “to go with a begging bowl to the multinationals” for licenses. This interview provides not only a personal perspective on how India’s third largest pharmaceutical firm was created, but contributes to the broad debates on the costs and benefits of intellectual property laws, particularly their impact on people who are denied life-saving drugs by their inability to pay for them. Working for Cipla as Managing Director for nearly 52 years, Yusuf was also the 28th richest Indian during one time. ‘CNN-IBN Indian of the year’ and one among the ’25 greatest global living legends’ were the titles that Yusuf won for his reign in the pharma world majorly for making medicines affordable to the poor. Yusuf was awarded with the civil honorary Padma Bhushan from then president APJ Abdul Kalam in the year 2005 for his fight against AIDS, which he often said was going to be as damaging to the society as a massive earthquake would be, if ignored. Yusuf earned his Bachelor's degree (1956), Master's degree (1957) and Ph.D. (1960) in Chemistry from University of Cambridge.
Show more
Investment focus
- Medical, Medical Device
- Seed
- United Kingdom
Portfolio highlights
- 1inhaler — 1inhaler operates as a developer of drug delivery device.
Robert Taub is the Co-Founder and Chairman at Nyxoah.
Show more
Investment focus
- Biotechnology, Medical, Hospital
- Funding Round, Series A, Series B
- Israel, Belgium, United Kingdom
Portfolio highlights
- LifeBond — LifeBond is a leader in the development and manufacturing of bio-surgical medical devices for tissue repair that are intended to improve the recovery of patients and to create an environment that supports the body’s natural healing process and promotes tissue repair. Of natural origin, elastic, adhesive, durable and yet absorbable, the company’sdevices can be used to fill a long list of unmet surgical needs. LifeBond’s first product, LifeSeal™, is designed to provide staple-line reinforcement in bariatric and colorectal operations. It was recently studied in an international pilot clinical study in Europe. The company’s second pipeline product, LifeMesh™, a self-fixating hernia mesh, is in pre-clinical development. Other pipeline products include tissue adhesives and absorbable hemostats. LifeSeal™, LifeMesh™ and other LifeBond™ products are investigational and have not yet been approved for sale in the US or in any other market. For more information please visit use at: www.life-bond.com
- ARCHIMEDICX — RateCare is the easiest way to understand hospital quality. We rate, rank and benchmark hospitals with a scientific, unbiased method for important decisions. Our system is powered by a unique and HIMSS certified-unbiased algorithm developed by ARCHIMEDICX, which runs on one of the largest hospital procedural databases. Our data and tools areavailable for patients, hospitals and companies needing to make healthcare price/quality decisions. The RateCare team is dedicated to a patient-centric, transparent and sensible approach to measuring Hospital quality and pricing worldwide. Join us on www.ratecare.com
- EyeD Pharma — We are EyeD Pharma, a clinical stage pharmaceutical company dedicated to improve the life of patients suffering from ophthalmic diseases.
Jim Mellon
Show more
Investment focus
- Medical, Health Care, Pharmaceutical
- Series A, Funding Round
- United Kingdom
Portfolio highlights
- Beckley Psytech — Our mission is to help people suffering from neurological and psychiatric conditions by developing our pipeline of psychedelic compounds.
Reece is the Founder & CEO of RLC Ventures - an early-stage SEIS/EIS VC fund investing in technology companies primarily focused on Fintech, Enterprise and Gaming. He was awarded “Top 5 Asian Tech Investors” 2018 (KPMG & Diversity UK) and is the youngest-ever investor to profiled by The Sunday Times. Reece is a frequent keynote andpanel speaker at prominent industry events such as StartupGrind Europe and Fintech Live. Reece holds a BA in International Business from Durham University and is a Chartered Management Consultant (ACMA, CGMA) having started his career as a Management Consultant at EY.Reece invests personally in all of RLC Ventures' investments.
Show more
Investment focus
- Software, Financial Services, FinTech
- Seed, Pre-Seed, Equity Crowdfunding
- United Kingdom, Canada, United States
Portfolio highlights
- Odin — Community and investment tools for people building the future.
- Condense — Live-streamed volumetric video into game engines
- Crowd Data Systems — Crowd Data Systems (CDS) offers a new approach to treasury management. CDS has developed an ‘app by app’ Treasury Management System which is built upon cloud infrastructure, offering everything from cash to exposure management in modular parts.
1989, Master's in Finance, Univ. of St Gallen, Switzerland; 1991, MBA in Finance, Graduate School of Business, Univ. of Chicago. Former: Partner, private management buy-out group, Switzerland; finance and systems positions, Sandoz and Computerland; finance, operations, management and sales positions, computer and software trading start-upcompanies, Europe, US. 1993, joined QIAGEN, when the company had just 30 employees and revenues of approximately $2 million. Former Member, German Corporate Governance Commission. Director: AdvaMedDx (US in-vitro diagnostics industry organization); ALDA (Analytical, Life Science & Diagnostics Association).
Show more
Investment focus
- Medical, Genetics, Health Care
- Seed
- United States, United Kingdom
Portfolio highlights
- Valar Labs — AI to Make Oncologists Smarter
- Relation Therapeutics — Relation uses machine learning to develop drugs for pressing unmet need.
Henry is a trained doctor with extensive hospital experience who co-founded Four Eyes Insight to put his talent for finding strategic solutions and planning into helping the NHS.His interest in medical resource management developed during his junior doctor training at Bart’s and the Royal London and he helped trusts tackle the significantchallenges of rotas and the New Deal as Junior Doctors’ Advisor at the London Regional Action Team.Establishing Zircadian Ltd, a software development company focusing on a portfolio of solutions to help NHS organisations plan and organise their medical workforce more strategically and effectively in 2000, he sold it on 11 years later to Allocate with over 140 NHS clients using its products.
Show more
Investment focus
- Medical, Health Care, Health Diagnostics
- Series A
- United Kingdom
Portfolio highlights
- Hexarad — Hexarad is a radiologist-led radiology company, which combines powerful tech and expert people to provide quick, accurate diagnoses. We have developed the Hexarad Platform, a unique and all-encompassing radiology solution powered by an intelligent allocative efficiency engine.
Jim Breyer - Co-Founder @ Accel-KKR
Show more
Investment focus
- Health Care, Software, Information Technology
- Series B, Series A, Series C
- United States, United Kingdom, Singapore
Portfolio highlights
- Zeck — Create smarter, modern board updates optimized for superior readability to better engage and inform your board and investors. Run perfect board meetings.
- Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with Artera. Transforming cancer therapy through innovation.
- OpenEvidence — OpenEvidence uses artificial intelligence to aggregate, synthesize, and visualize clinical evidence in understandable, clinically-useful formats that can be used to make more evidenced-based decisions and improve patient outcomes.
Frederic H. Moll, M.D. serves as Chief Development Officer of Johnson & Johnson’s Digital Surgery Group. Prior to Johnson & Johnson, Dr. Moll was CEO of Auris Health, Inc., located in Redwood City, California. Prior to Auris, Dr. Moll founded Hansen Medical and served as the company’s first CEO, and in 1995, founded Intuitive Surgical,Inc. (Nasdaq: ISRG).Dr. Moll earned a M.D. from the University of Washington, School of Medicine, a M.S. degree in Management from Stanford University’s Sloan Program, and a B.A. degree from the University of California at Berkeley.
Show more
Investment focus
- Medical Device, Health Care, Medical
- Seed, Series A, Angel
- United States, United Kingdom, The Netherlands
Portfolio highlights
- Mendaera — Mendaera enables all healthcare providers to perform precise and consistent point-of-care interventions. Their platform combines real-time imaging, robotics, and artificial intelligence to aid physicians in image acquisition and interpretation.
- Bright Uro — Actionable Insight Improves Outcomes
- Proclaim — Proclaim is a revolutionary, at-home, custom-jet oral irrigator that provides patients with the easiest, fastest, most effective at-home oral care.
Jon Moulton is a British venture capitalist. He is the founder and managing partner of the private equity firm Better Capital, and is the former managing partner of the private equity firm Alchemy Partners.
Show more
Investment focus
- Financial Services, FinTech, Banking
- Funding Round, Seed, Series A
- United Kingdom, Cyprus, Luxembourg
Portfolio highlights
- Pockit — Open a prepaid account in 3 minutes online or in-app, get your contactless prepaid card in 2 working days with no credit check.
- Hometree — Keep yourself warm with Hometree, and try our no price hike promise. Compare our different boiler & home cover plans to see how you can save.
- Hellas Direct — Hellas Direct is a digital-first, full-stack insurance company, empowered by cutting-edge technology and artificial intelligence. The Cyprus-based company is backed by a roster of leading investors, including Portag3, IFC (a member of the World Bank), Endeavor Catalyst, former Goldman Sachs economist Lord O’Neill and private equity veteran JonMoulton. Modelling itself on Amazon, Hellas Direct aims to disrupt the insurance value chain by adopting an extreme focus on operational excellence.
Dr. Desai brings a variety of medical industry, health policy, and clinical academic experiences to Avinger. Initially joining Avinger as a consultant in 2009, Dr. Desai helped to direct and publish the pivotal CONNECT study, which successfully established FDA clearance for Avinger’s Wildcat and Kittycat CTO crossing catheters. After joiningAvinger full time in 2012, Dr. Desai has expanded his focus to oversee health economics, reimbursement, clinical evidence generation, and scientific theory. In that time, Avinger has successfully published more than twenty manuscripts, clinical conference presentations, and case series. Most recently, Dr. Desai and his team successfully conducted and published the first ever peer reviewed Lumivascular manuscripts hallmarking a large European case series and the landmark CONNECT II clinical trial for the Ocelot catheter. Prior to Avinger, Dr. Desai served as a consultant and advisor for Incline Therapeutics, developing the IONSYS transdermal fentanyl delivery system. Additionally, Dr. Desai has consulted with pharmaceutical development targeting cancer therapeutics and healthcare IT development for capture of real time quality- metric assessment and implementation.Prior to management consulting, Dr. Desai served as a fellow in the US House Policy Committee, advising members of Congress on healthcare legislation. Additionally, Dr. Desai represented the US State Department and Rotary International as an Ambassador of Goodwill to Singapore where he led vaccine prophylaxis campaigns and lectured in the department of health economics at the National University of Singapore.Dr. Desai maintains his clinical practice as adjunct faculty at Stanford University in the department of Anesthesia where he completed his advanced anesthesia residency training. Dr. Desai holds an M.D. from the University of Miami Miller School of Medicine and a B.A. in Economics from the University of Oklahoma.
Show more
Investment focus
- Medical, Health Care, Medical Device
- Seed
- United Kingdom
Portfolio highlights
- TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
Tracy Dorée is a Founding Partner Kindred Capital. Tracy Dorée is the Co-Founder of Fab UK and serves as its Chief Executive Officer. She serves as Senior Vice President of Merchandising & Design for Europe at Fab, Inc. Tracy Dorée serves as an Investment Manager at MMC VENTURES Ltd. She joined MMC VENTURES in 2008 and is a Member of Investmentteam. Tracy Dorée is responsible for sourcing and executing new investments and managing individual portfolio companies. Prior to this, she gained experience in investment banking at NM Rothschild and strategy consulting at Accenture. Tracy Dorée served as Non-Executive Director of Base79 Limited. She holds a M.A. in Mathematics (first) from Balliol College, Oxford University.
Show more
Investment focus
- FinTech, Medical, Wellness
- Seed, Pre-Seed
- United Kingdom
Portfolio highlights
- Dishpatch — Dispatch is a finish-at-home meal kit platform that claims to bring the best of London’s ‘world-beating’ food scene to homes across the UK
- Nosso — Nosso is a mobile-based financial planning platform for the future of children.
- The Lowdown — 39K Followers, 1,214 Following, 723 Posts - See Instagram photos and videos from The Lowdown (@get.the.lowdown)
William Armitage is the Co-Founder & CFO ,Advisor of The Game Day.
Show more
Investment focus
- FinTech, Software, Health Care
- Seed, Angel, Pre-Seed
- United Kingdom, Chile
Portfolio highlights
- Global 66 — Global 66 is an international online payment platform that allows customers to transfer money with rates up.
- Tallarium — Tallarium - The definitive pre-trade data and analytics platform for OTC energy markets, driven by data science
- Alphagreen Group — Alphagreen Group is a global acquisition and incubation platform with a health & wellness focus. We help brands to scale via our own distribution channels and an extensive external omni-channel network. Build: We build brands using our marketplace and other sources to inform us on consumer demand. We automate the sales of products acrossvarious eCommerce channels, from DTC, on Alphagreen.io, Amazon, affiliates and other channelsAcquire: We acquire high calibre profitable health and wellness brands. We use our data and network to qualify existing products to forecast future growth and automate the management of assets once acquiredScale: We scale brands using our expertise in growth hacking, existing tech infrastructure and an experienced team. Distribution includes via DTC, alphagreen.io and external marketplaces such as Amazon.
Stephen Bourke
Show more
Investment focus
- Health Care, Medical, Wellness
- Pre-Seed, Angel
- United Kingdom
Portfolio highlights
- Jude — Hey, we're Jude. A healthcare start-up on a mission is to bring bladder care into the mainstream.
- Habitual — Our diabetes remission programme combines digital therapeutics with diet and habit change. Our personalised programme delivers type 2 diabetes reversal and weight loss.
- Syndi Health — Meet Syndi Health: an all-in-one platform for aggregating, recommending, and paying for digital health services - amplifying your employee wellbeing support with 0% admin.
Dr. Maurice R. Ferré was the founding President and Chief Executive Officer of MAKO Surgical Corp, serving from 2004 until the acquisition of the company by Stryker Corp. for $1.7 billion in 2014.In June 2007, Dr. Ferré received the Ernst & Young Entrepreneur of the Year 2007 award for emerging companies in Florida. In 1993, he foundedVisualization Technology, Inc., a medical device company for image-guided surgery, where he served as Chief Executive Officer until 2002 when the company was acquired by GE Healthcare, the healthcare division of the General Electric Company. Dr. Ferré served as Vice President of Strategic Development for GE Navigation, a Division of GE Healthcare, until 2004.Dr. Ferré holds an M.D. and a Master’s degree in Public Health from Boston University.
Show more
Investment focus
- Medical Device, Medical, Health Care
- Series A, Seed, Angel
- United States, United Kingdom
Portfolio highlights
- Heru — Discover the future of vision care and virtual eye exams with Heru. Click to learn about our AR eye machines and virtual visual field exams.
- TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
- DermaSensor — We've built a handheld, objective device to assist primary care providers in evaluating skin lesions for the risk of cancer in seconds. Early detection saves lives.
Dr. McCamish is President and Chief Executive Officer of IconOVir Bio. Previously he was President and Chief Executive Officer of Forty Seven, Inc. He led Forty Seven, Inc. during critical phases of clinical development to help patients defeat their cancer. This included growing from a valuation of $169 million as a private company through a SeriesB offering, Initial Public Offering, two secondary fund raises and finally the acquisition of Forty Seven by Gilead for $4.9 Billion.He is an international expert in biologic and biosimilars development and manufacturing. Mark is passionate about mentoring and developing people while focusing on meeting patient needs through efficient, commercially viable efforts. He is a senior executive with extensive experience at multiple companies including Abbott, Amgen, and Novartis/Sandoz. He led pioneering efforts in filing/launching biosimilars worldwide. He has demonstrated a commercial mindset in establishing research and development strategies leading to approvals and commercial success in multiple therapeutic areas and regulatory categories including biologics, biosimilars, drugs, devices, and medical foods.He received Bachelor’s and Master’s degrees from UCSB and, after completing his PhD in Human Nutrition from Penn State and MD from UCLA, he completed Residency and Fellowship Training at the University of California, Davis. He held professorships at UC Davis and The Ohio State University
Show more
Investment focus
- Medical, Biopharma, Biotechnology
- Seed
- United Kingdom
Portfolio highlights
- Nemesis Bioscience — Nemesis Bioscience is a UK-based biopharmaceutical company developing products to resurrect anti-microbial therapies made ineffective by increasing microbial resistance. The company develops Nemesis Symbiotics that will make existing antibiotics work again, prevent the spread of resistance genes, and so also protect the efficacy of new antibiotics.The technology is applicable to all antibiotic classes, all known resistance mechanisms and all bacteria.Other applications include reduction of chemotherapeutic toxicity, inactivation of virulence factors, and in vivo synthesis of biofuels and therapeutics.The company was awarded the King’s College, Cambridge Entrepreneurship Award for 2014 and has filed patent applications internationally on its inventions.
Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics.
Show more
Investment focus
- E-Commerce, Software, Financial Services
- Seed, Angel, Pre-Seed
- Spain, United States, United Kingdom
Portfolio highlights
- Bankflip — Permissioned data technology to collect and process your customers' income, tax, employment & other relevant data & documents in real-time
- Libera Bio — Libera Bio is a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer
- Mable (Neurolytic Healthcare) — Neurolytic Healthcare provides personalized medicine for neurological conditions. Neurolytic Healthcare collects and extracts insights from a combination of genetic and biomarker data to enhance diagnosis and help clinicians decide on optimal treatment strategies for neurological conditions.The company delivers digitally and genomically-drivenmedical devices to improve the current treatment of migraine and other neurological disorders, including a diagnostic support tool, pharmacogenetic test, and a mobile app for migraine event prediction.
Mark Cuban is the founder of Fireside, Chairman and Founding Partner of AXS TV, and the Owner of Dallas Mavericks. He previously worked at Broadcast.com as a Co-Founder. Mark Cuban attended the Indiana University Bloomington.
Show more
Investment focus
- Blockchain, Software, E-Commerce
- Seed, Series A, Angel
- United States, Vietnam, Singapore
Portfolio highlights
- Bot-It — Online automation for everyone. Let Bot-It automatically complete your online tasks.
- Allstar — Allstar is a gaming company that believes every gamer can become a content creator, with the right tools. The company is driven by its mission is to make the everyday gamer the star of their greatest esports moments through technology that enables them to effortlessly create, discover, and share their own professional quality esports highlights.
- Glove Wrap — Glove Wrap is a latex-free, thermoplastic elastomer band with the precise thickness, width, and length required to break in and shape your complete baseball glove while making the ideal pocket. Wrapping your glove with Glove Wrap applies pressure to the glove, reshaping it for easy use.
Principal at Apax Digital.
Show more
Investment focus
- Rental, Medical, Software
- Series A, Series D, Series E
- Israel, United Kingdom
Portfolio highlights
- Guesty — Guesty simplifies the way property managers work.
- MIP Diagnostics — MIP Diagnostics develop and manufacture molecularly imprinted polymers (nanoMIPs) that act as synthetic alternatives to antibodies for IVD and other industries.
He was a founding partner and chairman of NewSmith Asset management, a fund manager for a wide range of institutional, pension fund and high net worth investors. Having started his career at the stockbroking firm Kemp Gee he subsequently became senior partner following the merger with Scrimgeour Vickers and Citibank. In 1988 he joined Smith Newcourt, the leading market making firm on the London Stock Exchange and as CEO, together with chairman Michael Marks merged the business with Merrill Lynch in 1995. At Merrill, Paul held a number of senior positions including head of Global Equities and in 2001 was made EVP and president of Merrill Lynch Global Markets and investment banking, responsible for the firm’s investment banking, debt and equity business worldwide. He left Merrill in 2003 to start NewSmith.He has served as a non executive director of Benfield plc and Cenkos securities and is currently Chairman of New River Retail plc the leading UK REIT specialising in retail property investment.Between 2007 and 2013 Paul served two terms as Chairman of the newly created British Horse Racing Authority, responsible for the Governance and Regulation of the country’s second largest sport. He is now Chairman of ROR, the sports main charity, responsible for ensuring that horses are cared for, retrained, and re-homed, after their racing careers are over.
He has a Bachelor of Arts (Honours) degree in Economics from Liverpool University and in 2009 was awarded an Honoury Doctorate of Law from Liverpool University.
Show more
Investment focus
- Fitness, Medical, Wellness
- Seed
- United Kingdom
Portfolio highlights
- Qured — Get affordable and reliable PCR Fit to Fly tests and Antigen Fit to Fly tests from Qured. Fast results. Recommended by global airlines, UKAS accredited.
Life Sciences Investor & Board member | Former EVP & COO Thermo Fisher Scientific
Show more
Investment focus
- Medical, Genetics, Health Care
- Seed
- United Kingdom
Portfolio highlights
- Relation Therapeutics — Relation uses machine learning to develop drugs for pressing unmet need.
Investors by industry
Energy
Climate
Health Care
Gaming
Hardware
Artificial intelligence
Impact
Proptech
Marketplace
Community
FinTech
Google
Consumer
Biotech
EdTech
Sustainability
Venture Capital
Beauty
B2B
Photography
Finance
Real Estate
Big Data
Web3
Clean Energy
Oil and Gas
Video Games
Food and Beverage
Publishing
Education
Payments
Fashion
Organic Food
Retail
Financial Services
Infrastructure
Social Media
Medical
Email
Art
Wellness
Music
Mobile
Franchise
Social Network
Platforms
Mobile Advertising
Local
Biotechnology
Internet
Hospitality
Fitness
Digital Media
Travel
Recruiting
Cannabis
Construction
Wine And Spirits
Medical Device
Manufacturing
Crowdfunding
Social
eSports
Automotive
CleanTech
Sports
Enterprise Software
Transportation
Legal
Mobile Apps
InsurTech
Enterprise
Android
LGBT
Life Science
Theatre
Film
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Software
Celebrity
Cryptocurrency
Agriculture (agtech)
Media (entertainment)
Blockchain
Facebook
Investors by country
India
Germany
South Korea
United Kingdom
Australia
Ireland
New Zealand
Canada
United States
Spain
Indonesia
Singapore
South Africa
Africa
Qatar
Europe
LATAM
Middle East
Sri Lanka
Asia
Armenia
Vietnam
China
Japan
Saudi Arabia
Brazil
Oceania
Czech Republic
Morocco
Malta
Mali
Malaysia
Italy
Peru
Lithuania
Myanmar
Lebanon
Kuwait
Cayman Islands
Cambodia
Israel
Ecuador
Barbados
Costa Rica
Finland
Belarus
France
Estonia
Hong Kong
Denmark
Gibraltar
Chile
Bermuda
Belize
Georgia
Greece
Egypt
Hungary
Ethiopia
Faroe Islands
Algeria
Ghana
Belgium
Croatia
Bulgaria
Bahrain
Turkey
Serbia
Rwanda
El Salvador
Venezuela
Ukraine
Portugal
Sierra Leone
Zimbabwe
Sweden
Taiwan
Senegal
Uruguay
Uganda
Tunisia
San Marino
Slovenia
Zambia
Uzbekistan
Russian Federation
Seychelles
Thailand
Puerto Rico
Tajikistan
Togo
Poland
Tanzania
Dominican Republic
Nigeria
Azerbaijan
Namibia
Iceland
Iraq
Bahamas
United Arab Emirates
Honduras
Bolivia
Isle of Man
Luxembourg
Albania
Pakistan
Grenada
Jordan
Romania
Argentina
Bangladesh
Latvia
Cyprus
Oman
Colombia
Panama
Mexico
Kazakhstan
Liberia
Jersey
Philippines
Norway
Mauritius
Kenya
Liechtenstein
Nicaragua
Austria
Cameroon
Switzerland
Guatemala
Marshall Islands
Angel Investors in United Kingdom by industry
Transportation
Enterprise
Biotech
Climate
Impact
SaaS
Marketplace
Proptech
Artificial intelligence
Community
Hardware
Restaurants
Venture Capital
Film
Crowdfunding
Real Estate
CleanTech
Fashion
Financial Services
Cryptocurrency
Education
Finance
Payments
Food and Beverage
Medical
Medical Device
Cannabis
EdTech
Energy
Internet
Social Media
Art
Music
Mobile
Android
Blockchain
Software
Legal
Construction
Local
Enterprise Software
Sports
Manufacturing
Digital Media
Fitness
Automotive
Travel
Biotechnology
Platforms
Mobile Advertising
Gaming
Retail
Social
Beauty
Web3
B2B
Life Science
Sporting Goods
Photography
Publishing
Big Data
Renewable Energy
Clean Energy
Infrastructure
eSports
Mobile Apps
Health Care
Recruiting
Social Network
Sustainability
Hospitality
Non Profit
Organic Food
Agriculture (agtech)
FinTech
Media (entertainment)
Wine And Spirits
InsurTech
Email
Video Games
Wellness
Consumer
Social Impact